{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:20:05Z","timestamp":1793920805369,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2015R1D1A1A09059589"],"award-info":[{"award-number":["NRF-2015R1D1A1A09059589"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2500-z","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T08:57:21Z","timestamp":1496825841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia"],"prefix":"10.1186","volume":"17","author":[{"given":"In Ae","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Bae","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoan Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Wook","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Wook","family":"Eun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hwa","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"key":"2500_CR1","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1128\/AAC.48.12.4624-4630.2004","volume":"48","author":"M Matsuoka","year":"2004","unstructured":"Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48:4624\u201330.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","volume":"32","author":"TP Atkinson","year":"2008","unstructured":"Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956\u201373.","journal-title":"FEMS Microbiol Rev"},{"key":"2500_CR3","first-page":"326","volume":"56","author":"BW Eun","year":"2008","unstructured":"Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Inf Secur. 2008;56:326\u201331.","journal-title":"J Inf Secur"},{"key":"2500_CR4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3201\/eid1908.121455","volume":"19","author":"KB Hong","year":"2013","unstructured":"Hong KB, Choi EH, Lee HJ, Lee SY, Cho EY, Choi JH, et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis. 2013;19:1281\u20134.","journal-title":"Emerg Infect Dis"},{"key":"2500_CR5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/INF.0b013e31812e4b81","volume":"26","author":"NH Kim","year":"2007","unstructured":"Kim NH, Lee JA, Eun BW, Shin SH, Chung EH, Park KW, et al. Comparison of polymerase chain reaction and the indirect particle agglutination antibody test for the diagnosis of Mycoplasma pneumoniae pneumonia in children during two outbreaks. Pediatr Infect Dis J. 2007;26:897\u2013903.","journal-title":"Pediatr Infect Dis J"},{"key":"2500_CR6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2334-12-126","volume":"12","author":"N Miyashita","year":"2012","unstructured":"Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, et al. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect Dis. 2012;12:126.","journal-title":"BMC Infect Dis"},{"key":"2500_CR7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.pedneo.2012.11.016","volume":"54","author":"T Takei","year":"2013","unstructured":"Takei T, Morozumi M, Ozaki H, Fujita H, Ubukata K, Kobayashi I, et al. Clinical features of Mycoplasma pneumoniae infections in the 2010 epidemic season: report of two cases with unusual presentations. Pediatr Neonatol. 2013;54:402\u20135.","journal-title":"Pediatr Neonatol"},{"key":"2500_CR8","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/AAC.01684-08","volume":"53","author":"Y Liu","year":"2009","unstructured":"Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from shanghai, China. Antimicrob Agents Chemother. 2009;53:2160\u20132.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.02060-12","volume":"57","author":"F Zhao","year":"2013","unstructured":"Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57:1521\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR10","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1128\/JCM.01983-15","volume":"53","author":"PL Ho","year":"2015","unstructured":"Ho PL, Law PY, Chan BW, Wong CW, To KK, Chiu SS, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J Clin Microbiol. 2015;53:3560\u20134.","journal-title":"J Clin Microbiol"},{"key":"2500_CR11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s004310100775","volume":"160","author":"A Ferwerda","year":"2001","unstructured":"Ferwerda A, Moll HA. Groot Rd. respiratory tract infections by Mycoplasma peumoniae in childrne: a revies of diagnostic and therapeutic measures. Eur J Pediatr. 2001;160:483\u201391.","journal-title":"Eur J Pediatr"},{"key":"2500_CR12","volume":"1","author":"SJ Gardiner","year":"2015","unstructured":"Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev. 2015;1:CD004875.","journal-title":"Cochrane Database Syst Rev"},{"key":"2500_CR13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1348-0421.2001.tb01293.x","volume":"45","author":"N Okazaki","year":"2001","unstructured":"Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617\u201320.","journal-title":"Microbiol Immunol"},{"key":"2500_CR14","volume-title":"Performance standards for antimicrobial susceptibility testing-twenty-first information Spplement: approved standard M100-S21","author":"Clinical and Laboratory Standards Institute","year":"2011","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing-twenty-first information Spplement: approved standard M100-S21. Wayne, PA: CLSI; 2011."},{"key":"2500_CR15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","volume":"16","author":"M Morozumi","year":"2010","unstructured":"Morozumi M, Ubukata K, Takahashi T. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16:78\u201386.","journal-title":"J Infect Chemother"},{"key":"2500_CR16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.diagmicrobio.2010.03.004","volume":"67","author":"Y Liu","year":"2010","unstructured":"Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in shanghai. China Diagn Microbiol Infect Dis. 2010;67:355\u20138.","journal-title":"China Diagn Microbiol Infect Dis"},{"key":"2500_CR17","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/AAC.01563-08","volume":"53","author":"D Xin","year":"2009","unstructured":"Xin D, Mi Z, Han X, Qin L, Li J, Wei T, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother. 2009;53:2158\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3201\/eid\/1706.101558","volume":"17","author":"D Averbuch","year":"2011","unstructured":"Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis. 2011;17:1079\u201382.","journal-title":"Emerg Infect Dis"},{"key":"2500_CR19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/jac\/dkr003","volume":"66","author":"M Chironna","year":"2011","unstructured":"Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011;66:734\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"2500_CR20","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1128\/AAC.00582-08","volume":"52","author":"BJ Wolff","year":"2008","unstructured":"Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008;52:3542\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR21","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1128\/AAC.49.6.2302-2306.2005","volume":"49","author":"M Morozumi","year":"2005","unstructured":"Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S, Kuroki H, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother. 2005;49:2302\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005054880109","volume":"5","author":"CM Bebear","year":"2005","unstructured":"Bebear CM, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr Drug Targets Infect Disord. 2005;5:263\u201371.","journal-title":"Curr Drug Targets Infect Disord"},{"key":"2500_CR23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/AAC.00779-07","volume":"52","author":"M Morozumi","year":"2008","unstructured":"Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2008;52:348\u201350.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/jama.1961.03040150034009","volume":"176","author":"JR Kinston","year":"1961","unstructured":"Kinston JR, Chanock RM, Mufson MA, Hellman LP, James WD, Fox HH, et al. Eaton agent pneumonia. JAMA. 1961;176:118\u201323.","journal-title":"JAMA"},{"key":"2500_CR25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1469-0691.2002.00392.x","volume":"8","author":"IA Critchley","year":"2002","unstructured":"Critchley IA, Jones ME, Heinze PD, Hubbard D, Engler HD, Evangelista AT, et al. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe. Clin Microbiol Infect. 2002;8:214\u201321.","journal-title":"Clin Microbiol Infect"},{"key":"2500_CR26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jhm.1904","volume":"7","author":"SS Shah","year":"2012","unstructured":"Shah SS, Test M, Sheffler-Collins S, Weiss AK, Hall M. Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia. J Hosp Med. 2012;7:311\u20137.","journal-title":"J Hosp Med"},{"key":"2500_CR27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1542\/peds.2013-3729","volume":"133","author":"E Biondi","year":"2014","unstructured":"Biondi E, McCulloh R, Alverson B, Klein A, Dixon A, Ralston S. Treatment of mycoplasma pneumonia: a systematic review. Pediatrics. 2014;133:1081\u201390.","journal-title":"Pediatrics"},{"key":"2500_CR28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1440-1843.2011.02102.x","volume":"17","author":"Y Kawai","year":"2012","unstructured":"Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Respirology. 2012;17:354\u201362.","journal-title":"Respirology"},{"key":"2500_CR29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","volume":"15","author":"K Matsubara","year":"2009","unstructured":"Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009;15:380\u20133.","journal-title":"J Infect Chemother"},{"key":"2500_CR30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","volume":"50","author":"S Suzuki","year":"2006","unstructured":"Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006;50:709\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"2500_CR31","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/cis784","volume":"55","author":"T Okada","year":"2012","unstructured":"Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55:1642\u20139.","journal-title":"Clin Infect Dis"},{"key":"2500_CR32","first-page":"S42","volume":"69","author":"EB Spuesens","year":"2014","unstructured":"Spuesens EB, Meyer Sauteur PM, Vink C, van Rossum AM. Mycoplasma pneumoniae infections-does treatment help? J Inf Secur. 2014;69:S42\u20136.","journal-title":"J Inf Secur"},{"key":"2500_CR33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1442-200X.2008.02644.x","volume":"50","author":"N Othman","year":"2008","unstructured":"Othman N, Isaacs D, Daley AJ, Kesson AM. Mycoplasma pneumoniae infection in a clinical setting. Pediatr Int. 2008;50:662\u20136.","journal-title":"Pediatr Int"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2500-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T08:57:29Z","timestamp":1496825849000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2500-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2500"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2500-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,7]]},"article-number":"402"}}